Cargando…
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the responsible agent for the coronavirus disease 2019 (Covid-19), has its entry point through interaction with angiotensin converting enzyme 2 (ACE2) receptors, highly expressed in lung type II alveolar cells and other tissues, like hear...
Autores principales: | Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Almulaiky, Yaaser Q., Cruz-Martins, Natália, El-Saber Batiha, Gaber |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123523/ https://www.ncbi.nlm.nih.gov/pubmed/34004207 http://dx.doi.org/10.1016/j.ejphar.2021.174196 |
Ejemplares similares
-
Montelukast and Acute Coronary Syndrome: The Endowed Drug
por: Alomair, Basil Mohammed, et al.
Publicado: (2022) -
COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Pleiotropic Effects of Tetracyclines in the Management of COVID-19: Emerging Perspectives
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021) -
Case Report: Hyperbilirubinemia in Gilbert Syndrome Attenuates Covid-19-Induced Metabolic Disturbances
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)